AbbVie's profit beats on robust Humira demand

(Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news